Table 2.
AKI model | Redox-Signalling-Induced Inflammasome Activation | Effects | Reference |
---|---|---|---|
PQ-induced nephrotoxicity | ROS/NF-κB/DAPK/NLRP3 | PQ produces ROS, activating to NF-κB and DAPK that in turn activates NLRP3 | [98] |
Methotrexate-induced nephrotoxicity | decreasedNrf2/ARE/HO-1 signalling and PPARγ | Methotrexate induces the decreasing of Nrf2 and PPARγ by promoting ROS, leading to antioxidant system decrease and lipid peroxidation | [99] |
Ceftriaxone-induced urolithiasis | decreasedNrf2/HO-1 | Ceftriaxone promotes inflammation and oxidative stress by activating NLRP3 and inducing ROS production and decreasing the antioxidant system. | [100] |
NF-κB: nuclear factor κB; NLRP3: Nod-like receptor (NLR) family pyrin domain containing 3; Nrf2: nuclear factor erythroid 2-related factor 2; ROS: reactive oxygen species; PQ: paraquat; DAPK: death-associated; antioxidant response element (ARE); heme oxygenase 1 (HO-1); PPARγ: peroxisome proliferator-activated receptor-gamma; mitogen-activated protein kinases (MAPK).